Results 81 to 90 of about 1,415,608 (192)
Seventh Åland Island Meeting on von Willebrand Disease
ABSTRACT Introduction The seventh Åland Island Meeting on von Willebrand Disease (VWD) was held on the Åland archipelago in Finland, from 26 to 28 September 2024. Aim The meeting brought together experts in the field of VWD from around the world to share the latest advances and knowledge in VWD.
Riitta Lassila +17 more
wiley +1 more source
Symptoms, Diagnosis, and Treatment for Women and Girls With Hemophilia: A Narrative Review
ABSTRACT Introduction Hemophilia is an X‐linked bleeding disorder previously thought to present only in men. This sentiment is rapidly changing as the information around women and girls’ experiences of bleeding symptoms has evolved, sparking intense discussion among researchers, clinicians, patients, and patient advocates regarding appropriate ...
Sam Hirniak +6 more
wiley +1 more source
Actinomycosis, a rare chronic bacterial infection caused by Actinomyces species, presents diagnostic challenges due to diverse clinical presentations.
Willbroad Kyejo +6 more
doaj +1 more source
Vesical Calculus 10 Years Post Missing Intrauterine Contraceptive Device [PDF]
Intravesical migration of intrauterine contraceptive device (IUCD) is rare. Early diagnosis of this rare entity is difficult because of its non‑specific manifestations and very low index of suspicion.
Abdulwahab‑Ahmed, A, Ogunleye, OO
core
Comparison of genital microbial isolates between intrauterine contraceptive device users and nonusers in Sokoto, Nigeria [PDF]
Background: In the past, the use of intrauterine contraceptive device (IUCD), in particular, Dalkon Shield was found to be associated with increased risk of pelvic infection. Recent literature illustrates that the risk of pelvic infection after insertion
Amin, Jamila +15 more
core +1 more source
Tolerability of hormonal treatments in acute hepatic porphyria patients
Abstract Background Acute hepatic porphyria (AHP) flares have been associated with female hormones and the use of hormonal treatments. Women with AHP are traditionally advised to avoid exogenous oestrogen and progesterone, limiting options for contraception and management of menorrhagia, dysmenorrhoea and menopausal symptoms.
Andjela Arandjelovic +2 more
wiley +1 more source
The Choice between Intrauterine Contraceptive Device Options: A Narrative Review
Deciding on intrauterine device selection requires consideration of multiple factors beyond contraceptive efficacy. Device frame dimensions relative to uterine cavity size, differences in bleeding and pain profiles between copper and levonorgestrel ...
Elliot M. Levine +2 more
core +1 more source
Intrauterine contraceptive device (IUCD) migration to the urinary bladder: A case report [PDF]
We highlight a unique case of an intravesical intrauterine contraceptive device (IUCD) that was discovered incidentally in the course of evaluation for secondary infertility in a woman who denied knowledge of insertion of the device.
F Anolue +7 more
core +1 more source
The use of OC has been demonstrated to enhance the likelihood of encountering self‐reported headaches and increased tenderness to palpation within the masticatory system in female adolescents. ABSTRACT Background The utilisation of oral contraceptives (OCs) has been demonstrated to be associated with the self‐reported occurrence of headaches in female ...
Henriette I. U. Stasche +6 more
wiley +1 more source
Intrauterine device is a widely used contraceptive method. However, it may translocate to other sites within the pelvic cavity, including the intestines and the bladder.
Dina Marlina +3 more
doaj +1 more source

